UNIVERSITY OF WASHINGTON
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery
- Conditions
- Recurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid CancerStage IVB Follicular Thyroid CancerStage IVB Papillary Thyroid CancerStage IVC Follicular Thyroid CancerStage IVC Papillary Thyroid Cancer
- Interventions
- Drug: pazopanib hydrochlorideRadiation: iodine I 131
- First Posted Date
- 2011-08-10
- Last Posted Date
- 2015-11-05
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 6
- Registration Number
- NCT01413113
- Locations
- πΊπΈ
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
- Conditions
- Stage IIIB Non-small Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung Cancer
- Interventions
- Radiation: 3-dimensional conformal radiation therapyRadiation: intensity-modulated radiation therapyDrug: cisplatinDrug: etoposide
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2015-11-04
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 6
- Registration Number
- NCT01411098
- Locations
- πΊπΈ
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Depression and ART Adherence in HIV+ Latinos
- Conditions
- HIV InfectionsDepressive Symptoms
- Interventions
- Behavioral: Cognitive-Behavioral Therapy (CBT-AD)
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2018-03-19
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 40
- Registration Number
- NCT01411839
- Locations
- πΊπΈ
Centro de Salud Familiar La Fe CARE Center, El Paso, Texas, United States
Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma
- Conditions
- Hemorrhagic ShockBlunt TraumaPenetrating Wound
- Interventions
- Drug: 0.9% Sodium Chloride 2000 mL bolusDrug: 0.9% Sodium Chloride 250 mL bolus
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2015-01-13
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 192
- Registration Number
- NCT01411852
- Locations
- πΊπΈ
Alabama Resuscitation Center, University of Alabama, Birmingham, Alabama, United States
πΊπΈDallas Center for Resuscitation Research, University of Texas Southwestern Medical Center, Dallas, Texas, United States
πΊπΈPortland Resuscitation Outcomes Consortium, Oregon Health & Sciences University, Portland, Oregon, United States
CoQ10 Biomarker Trial
- Conditions
- InflammationOxidative StressEndothelial Dysfunction
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Coenzyme Q10
- First Posted Date
- 2011-08-03
- Last Posted Date
- 2014-12-04
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 66
- Registration Number
- NCT01408680
- Locations
- πΊπΈ
Northwest Kidney Centers, Seattle, Washington, United States
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
- Conditions
- Cardiac Arrest
- Interventions
- First Posted Date
- 2011-07-25
- Last Posted Date
- 2017-04-17
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 3024
- Registration Number
- NCT01401647
- Locations
- πΊπΈ
Alabama Resuscitation Center, Birmingham, Alabama, United States
πΊπΈPortland Resuscitation Outcomes Consortium, Oregon Health & Sciences University, Portland, Oregon, United States
π¨π¦University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research, Ottawa, Ontario, Canada
Preterm Erythropoietin Neuroprotection Trial (PENUT Trial)
- Conditions
- Extreme Prematurity
- Interventions
- Other: ControlDrug: Epo
- First Posted Date
- 2011-06-22
- Last Posted Date
- 2020-08-26
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 941
- Registration Number
- NCT01378273
- Locations
- πΊπΈ
Wake Forest School of Medicine, Winston-Salem, North Carolina, United States
πΊπΈFlorida Hospital, Orlando, Florida, United States
πΊπΈUniversity of New Mexico Children's Hospital, Albuquerque, New Mexico, United States
Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
- Conditions
- ClaudicationPeripheral Arterial Disease
- First Posted Date
- 2011-06-22
- Last Posted Date
- 2017-05-18
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 323
- Registration Number
- NCT01378260
- Locations
- πΊπΈ
University of Washington, Seattle, Washington, United States
πΊπΈGood Samaritan Hospital, Puyallup, Washington, United States
πΊπΈProvidence Sacred Heart Medical Center, Spokane, Washington, United States
Continuous Chest Compressions vs AHA Standard CPR of 30:2
- Conditions
- Out of Hospital Cardiac Arrest
- Interventions
- Other: Continuous chest compressionsOther: Standard CPR
- First Posted Date
- 2011-06-14
- Last Posted Date
- 2016-12-28
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 23711
- Registration Number
- NCT01372748
- Locations
- πΊπΈ
Seattle-King County Center for Resuscitation Research, Seattle, Washington, United States
πΊπΈMilwaukee Resuscitation Network, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
πΊπΈAlabama Resuscitation Center, Birmingham, Alabama, United States
The Effects of Multiple Dose Fluoxetine and Metabolites on CYP1A2, CYP2C19, CYP2D6 and CYP3A4 Activity
- Conditions
- Drug-Drug InteractionHealthy Volunteers
- Interventions
- First Posted Date
- 2011-05-26
- Last Posted Date
- 2018-06-29
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 10
- Registration Number
- NCT01361217